Oncology & Cancer

Beta-adrenergic receptor signaling affects tumor microenvironment

(HealthDay)—β2-adrenergic receptor (β-AR) signaling in host immune cells regulates CD8+ T-cell frequency and functional orientation within the tumor microenvironment, according to a study published online Aug. 17 in Cancer ...

Oncology & Cancer

A new strategy to transform liver cancer immunotherapy

In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach. It is based on using humanized antibodies called immune checkpoint inhibitors (ICIs) to block the cellular pathways ...

Oncology & Cancer

Improving cancer diagnostics through microfluidics

Dr. Raphael Pollock has earned the reputation as one of the world's best surgical oncologists for patients facing one of the toughest cancers to treat, sarcoma. Frequently these tumors start out in the very deepest recesses ...

Oncology & Cancer

Area surrounding a tumor impacts how breast cancer cells grow

Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.

Oncology & Cancer

Researchers harness immune system to fight pancreatic cancer

(Medical Xpress)—Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and ...

Oncology & Cancer

Novel lymphoma tumor model paves way for new therapies

In recent years, innovative cancer drugs that target specific molecular drivers of the disease have been embraced as the treatment of choice for many types of cancer. But despite significant advances, there is still a lack ...

page 26 from 40